Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer

Browse by...

Deposit

Highlights

More informations

Title		Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer
Authors		Yan, Pu Klingbiel, Dirk Saridaki, Zenia Ceppa, Paola Curto, Monica Mckee, Thomas Alexander Roth, Arnaud Tejpar, Sabine Delorenzi, Mauro Bosman, Fredrik T Fiocca, Roberto show all authors [1 - 11]
Published in		Clinical Cancer Research. 2016, vol. 22, no. 12, p. 3037-47
Abstract		SMAD4 loss is associated with the development of metastases and poor prognosis. We evaluated expression of SMAD4 protein and its association with tumor characteristics, including biomarkers and outcome in terms of relapse-free survival and overall survival.
Identifiers		DOI: 10.1158/1078-0432.CCR-15-0939 PMID: 26861460
Full text		Article (Accepted version) (1.7 MB) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
Research group		Lymphomes MALT et réplication virale (807)
Citation (ISO format)		YAN, Pu et al. Reduced Expression of SMAD4 Is Associated with Poor Survival in Colon Cancer. In: Clinical Cancer Research, 2016, vol. 22, n° 12, p. 3037-47. doi: 10.1158/1078-0432.CCR-15-0939 https://archive-ouverte.unige.ch/unige:84838